B&G Foods (BGS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Q3 2024 net sales declined 8.3% year-over-year to $461.1 million, primarily due to the Green Giant U.S. shelf-stable divestiture, lower unit volumes, and negative foreign currency impact, partially offset by improved pricing and product mix.
Net income for Q3 2024 was $7.5 million, a significant improvement from a net loss of $82.7 million in Q3 2023, mainly due to the absence of prior year impairment charges.
Consumer purchasing patterns remain subdued due to high food inflation, with only the spices and flavor solutions segment showing positive growth (+2.6%).
Major retail customers reduced inventories, impacting net sales by an estimated 1% in the quarter.
The company completed significant portfolio reshaping, including the divestiture of the Green Giant U.S. shelf-stable product line and Back to Nature business.
Financial highlights
Adjusted EBITDA for Q3 2024 was $70.4 million (15.3% of net sales), down from $80.4 million (16%) in Q3 2023.
Net income was $7.5 million ($0.09 per diluted share); adjusted net income was $10.1 million ($0.13 per diluted share).
Gross profit was $102.3 million (22.2% of net sales), down from $113.8 million (22.6%) last year.
Net interest expense increased to $42.2 million from $35.9 million year-over-year, mainly due to higher rates and refinancing costs.
Cash provided by operating activities for the first three quarters of 2024 was $50.6 million, down from $155.7 million in the prior year period.
Outlook and guidance
Fiscal 2024 guidance revised: net sales $1.92–$1.95 billion, adjusted EBITDA $295–$305 million, adjusted EPS $0.67–$0.77.
Q4 base business net sales expected to decline 2–3% year-over-year, mirroring Q3 trends.
Management expects gradual improvement and stabilization in sales trends into the first half of 2025 as the company laps consumer reaction to higher prices.
Full-year 2024 interest expense expected at $152.5–$157.5 million; CapEx $30–$35 million.
Aggregate dividend payments of approximately $60.2 million are anticipated in fiscal 2025, maintaining the current dividend rate.
Latest events from B&G Foods
- Portfolio transformation and divestitures drive margin gains and lower leverage for 2026.BGS
Q4 20253 Mar 2026 - Q2 sales fell 5.3%, goodwill impairment hit results, and guidance was revised lower.BGS
Q2 20242 Feb 2026 - Portfolio reshaping and operational improvements target margin recovery and 2024 growth.BGS
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Portfolio streamlining and cost initiatives aim to boost margins and enable future growth.BGS
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Sequential improvement, strong spices growth, and major impairments shape 2025 outlook.BGS
Q4 202418 Dec 2025 - Shelf registration allows up to $800M in securities for growth, debt, and acquisitions.BGS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.BGS
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification up for virtual shareholder vote.BGS
Proxy Filing1 Dec 2025 - Q1 2025 sales dropped 10.5% and EBITDA fell 21.2%, prompting lower guidance and cost cuts.BGS
Q1 202525 Nov 2025